Axogen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Axogen and other ETFs, options, and stocks.

About AXGN

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. 

CEO
Michael D. Dale
CEOMichael D. Dale
Employees
452
Employees452
Headquarters
Alachua, Florida
HeadquartersAlachua, Florida
Founded
1977
Founded1977
Employees
452
Employees452

AXGN Key Statistics

Market cap
1.87B
Market cap1.87B
Price-Earnings ratio
-719.39
Price-Earnings ratio-719.39
Dividend yield
Dividend yield
Average volume
741.78K
Average volume741.78K
High today
$36.10
High today$36.10
Low today
$34.89
Low today$34.89
Open price
$35.89
Open price$35.89
Volume
598.56K
Volume598.56K
52 Week high
$36.10
52 Week high$36.10
52 Week low
$9.22
52 Week low$9.22

Stock Snapshot

As of today, Axogen(AXGN) shares are valued at $35.01. The company's market cap stands at 1.87B, with a P/E ratio of -719.39.

On 2026-02-19, Axogen(AXGN) stock traded between a low of $34.89 and a high of $36.10. Shares are currently priced at $35.01, which is +0.4% above the low and -3.0% below the high.

Axogen(AXGN) shares are trading with a volume of 598.56K, against a daily average of 741.78K.

In the last year, Axogen(AXGN) shares hit a 52-week high of $36.10 and a 52-week low of $9.22.

In the last year, Axogen(AXGN) shares hit a 52-week high of $36.10 and a 52-week low of $9.22.

AXGN News

Simply Wall St 5h
The Bull Case For Axogen Could Change Following Institution-Led Uptrend And New Conference Push

Axogen recently confirmed it met the Minervini Trend Template, signaling an institution-led uptrend supported by improving earnings, sales trends, and analyst e...

The Bull Case For Axogen Could Change Following Institution-Led Uptrend And New Conference Push
TipRanks 11h
AxoGen initiated with an Overweight at Wells Fargo

Wells Fargo initiated coverage of AxoGen (AXGN) with an Overweight rating and $40 price target The firm says AxoGen is the only company fully focused on the tre...

Simply Wall St 2d
Assessing Axogen Valuation After Technical Strength And Growing Investor Conference Visibility

Axogen (AXGN) has drawn fresh attention after recent data flagged the stock as fitting the Minervini Trend Template, alongside management’s planned appearances...

Assessing Axogen Valuation After Technical Strength And Growing Investor Conference Visibility

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own AXGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.